Bradley Foster & Sargent Inc/Ct / TMO
Bradley Foster & Sargent Inc/Ct’s Thermo Fisher Scientific Inc Position
Does Bradley Foster & Sargent Inc/Ct own Thermo Fisher Scientific Inc (TMO)? Yes — 256.6K shares worth $126M (+1.96% of its 13F portfolio) as of Q1 2026, down from 259.0K shares the prior filed quarter.
Position Value
$126M
Q1 2026
Shares
256.6K
% of Portfolio
+1.96%
Quarters Held
28
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 256.6K | $126M | +1.96% |
| Q4 2025 | 259.0K | $150M | +2.20% |
| Q3 2025 | 244.0K | $118M | +1.74% |
| Q2 2025 | 242.5K | $98M | +1.54% |
| Q1 2025 | 243.4K | $121M | +2.07% |
| Q4 2024 | 204.1K | $106M | +1.79% |
| Q3 2024 | 202.5K | $125M | +2.09% |
| Q2 2024 | 199.9K | $111M | +1.99% |
| Q1 2024 | 200.0K | $116M | +2.10% |
| Q4 2023 | 200.8K | $107M | +2.07% |
| Q3 2023 | 183.1K | $96M | +2.01% |
| Q2 2023 | 183.1K | $96M | +2.01% |
| Q1 2023 | 177.2K | $102M | +2.44% |
| Q4 2022 | 177.6K | $98M | +2.45% |
| Q3 2022 | 179.4K | $91M | +2.52% |
| Q2 2022 | 180.2K | $98M | +2.52% |
| Q1 2022 | 192.5K | $114M | +2.43% |
| Q3 2021 | 193.7K | $111M | +2.60% |
| Q2 2021 | 193.4K | $98M | +2.28% |
| Q1 2021 | 194.0K | $89M | +2.24% |
| Q4 2020 | 193.7K | $90M | +2.38% |
| Q3 2020 | 216.8K | $96M | +2.80% |
| Q1 2020 | 222.3K | $63M | +2.52% |
| Q4 2019 | 229.6K | $75M | +2.30% |
| Q3 2019 | 231.3K | $67M | +2.25% |
| Q2 2019 | 234.6K | $69M | +2.28% |
| Q1 2019 | 235.1K | $64M | +2.25% |
| Q4 2018 | 238.1K | $53M | +2.15% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bradley Foster & Sargent Inc/Ct’s full portfolio or all institutional holders of TMO.